Small-cell transformation is a clinically resistant mechanism against epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in lung adenocarcinoma (LUAD). This evidence concerns the gene EGFR and lung adenocarcinoma.